Germany Clinical Chemistry Market Outlook to 2021
[Lowest Price Guaranteed: $2,500]

Introduction

Germany Clinical Chemistry Market Outlook to 2021

Summary

GlobalData’s new report, "Germany Clinical Chemistry Market Outlook to 2021", provides key market data on the Germany Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.

- 2014 company shares and distribution shares data for Clinical Chemistry market.

- Global corporate-level profiles of key companies operating within the Germany Clinical Chemistry market.

- Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the market.

- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents
for Germany Clinical Chemistry Market Outlook to 2021

• 1 Table of Contents

  1 Table of Contents 2

  1.1 List of Tables 4

  1.2 List of Figures 4

  2 Introduction 5

  2.1 What Is This Report About? 5

  2.2 Clinical Chemistry Market Segmentation 5

  2.3 Definitions of Markets Covered in the Report 6

  3 Clinical Chemistry Market, Germany 9

  3.1 Clinical Chemistry Market, Germany, Revenue ($m), 2007-2014 9

  3.2 Clinical Chemistry Market, Germany, Revenue ($m), 2014-2021 11

  3.2.1 Clinical Chemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2007-2014 13

  3.2.2 Therapeutic Drug Monitoring Market, Germany, Revenue ($m), by Segment, 2007-2014 15

  3.2.3 Urine Analysis Market, Germany, Revenue ($m), by Segment, 2007-2014 17

  3.2.4 Clinical Chemistry Analyzers Market, Germany, Revenue ($m), by Segment, 2014-2021 19

  3.2.5 Therapeutic Drug Monitoring Market, Germany, Revenue ($m), by Segment, 2014-2021 21

  3.2.6 Urine Analysis Market, Germany, Revenue ($m), by Segment, 2014-2021 23

  3.3 Clinical Chemistry Market, Germany, Distribution Share by Revenue ($m), 2013-2014 25

  3.4 Clinical Chemistry Market, Germany, Company Share by Revenue ($m), 2014 26

  4 Overview of Key Companies in Germany, Clinical Chemistry Market 28

  4.1 Siemens Healthcare 28

  4.1.1 Company Overview 28

  4.2 F. Hoffmann-La Roche Ltd. 28

  4.2.1 Company Overview 28

  4.3 Abbott Laboratories 28

  4.3.1 Company Overview 28

  4.4 Ortho-Clinical Diagnostics Inc. 29

  4.4.1 Company Overview 29

  4.5 Mindray Medical International Limited 29

  4.5.1 Company Overview 29

  4.6 ELITech Group 29

  4.6.1 Company Overview 29

  5 Clinical Chemistry Market Pipeline Products 30

  6 Financial Deals Landscape 33

  6.1 Partnerships 33

  6.1.1 NoemaLife Enters into Distribution Agreement with Horiba Medical 33

  6.1.2 Metabolon Enters into Co-Marketing Agreement with Metdia Biotech 34

  6.2 Venture Financing 35

  6.2.1 Ayoxxa Biosystems Raises USD2.9 Million in Extended Series B Venture Financing 35

  7 Recent Developments 37

  7.1 Financial Announcements 37

  7.1.1 Apr 28, 2015: Analytik Jena Enjoying Solid Start to New Financial Year 37

  7.1.2 Apr 22, 2015: Noxilizer and Getinge-La Calhene announce exclusive global supply agreement for Noxilizer to provide NOX FLEX Rapid Biodecontamination systems for Getinge isolators - providing a new solution for the bio-pharmaceutical industry 37

  7.1.3 Mar 30, 2015: 100th Patent in Three Years: The Result of a Successful Patent Strategy 40

  7.1.4 Mar 26, 2015: Rockwell Medical Announces Triferic Clinical Data Selected for Four Poster Presentations at National Kidney Foundation Spring Clinical Meetings March 26-29, 2015 in Dallas, Texas 41

  7.1.5 Mar 26, 2015: Eckert & Ziegler’s Annual Report 2014: Weak Therapy segment puts a strain on consolidated profit 43

  7.1.6 Feb 04, 2015: Drug-eluting technologies for PAD treatments take centre stage at LINC 2015 44

  7.1.7 Nov 27, 2014: Analytik Jena Devaluation Of The Ruble Necessitates Value Adjustment In The Project Business And Leads To A Clearly Negative Operating Result 46

  7.2 Other Significant Developments 46

  7.2.1 Feb 17, 2015: SGS Introduces Amino Acid Analytical Services At Its Taunusstein, Germany, Facility 46

  7.2.2 Jan 16, 2015: Agilent Technologies Names Alacris Theranostics as Certified Provider of Target Enrichment Services 47

  7.3 Product News 47

  7.3.1 Apr 27, 2015: Analytik Jena Launches New Gene Assembly Robot at SynBioBETA London 2015 47

  7.3.2 Jan 21, 2015: Analytik Jena Launches CE IvD Kits for Dementia Diagnostics 48

  7.4 Strategy And Business Planning 49

  7.4.1 Nov 06, 2014: Analytik Jena Establishes Subsidiary in India 49

  8 Appendix 50

  8.1 Research Methodology 51

  8.1.1 Coverage 51

  8.1.2 Secondary Research 51

  8.1.3 Primary Research 51

  8.1.4 Company Share Analysis 52

  8.1.5 Distribution Share Analysis 52

  8.2 GlobalData Consulting 52

  8.3 Contact Us 52

  8.4 Disclaimer 53

List Of Tables
in Germany Clinical Chemistry Market Outlook to 2021

1.1 List of Tables

Table 1: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 10

Table 2: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 12

Table 3: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 14

Table 4: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 16

Table 5: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 18

Table 6: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 20

Table 7: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 22

Table 8: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 24

Table 9: Clinical Chemistry Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2013-2014 25

Table 10: Clinical Chemistry Market, Germany, Company Share by Revenue ($m), USD Constant, 2014 27

Table 11: Clinical Chemistry Market Pipeline Products 30

Table 12: NoemaLife Enters into Distribution Agreement with Horiba Medical 33

Table 13: Metabolon Enters into Co-Marketing Agreement with Metdia Biotech 34

Table 14: Ayoxxa Biosystems Raises USD2.9 Million in Extended Series B Venture Financing 35

List Of Figures, Charts and Diagrams
in Germany Clinical Chemistry Market Outlook to 2021

1.2 List of Figures

Figure 1: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 9

Figure 2: Clinical Chemistry Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 11

Figure 3: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 13

Figure 4: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 15

Figure 5: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Historic, 2007-2014 17

Figure 6: Clinical Chemistry Analyzers Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 19

Figure 7: Therapeutic Drug Monitoring Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 21

Figure 8: Urine Analysis Market, Germany, Revenue ($m), USD Constant, Forecast, 2014-2021 23

Figure 9: Clinical Chemistry Market, Germany, Company Share (%) 2014 26

Additional Details

Publisher

Global Data

Publisher Information

Reference

17039 | GDMECC1222DB

Number of Pages

53

Report Format

PDF

Related Reports